Patents by Inventor Robert Hellwig

Robert Hellwig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9242038
    Abstract: A diabetes therapy device is disclosed herein, which includes a profile memory storing a parameter profile and a dedicated reference time mark. The parameter profile defines at least one parameter that is associated with insulin administration as a function of time for a generally circadian chronobiological cycle. The reference time mark indicates the beginning of the circadian chronobiological cycle and initializes a running time. Insulin amounts to be administered are determined as a function of the running time in accordance with a current matching of the parameter profile. A modified matching based on the reference time mark and an upcoming trigger time is computed and is time-shifted from the current matching, wherein the modified matching is applied by making the modified matching the current matching, such that future insulin amounts to be administered are determined in accordance with the modified matching.
    Type: Grant
    Filed: September 23, 2010
    Date of Patent: January 26, 2016
    Assignee: Roche Diagnostics International AG
    Inventors: Gilles Prod'hom, Thierry Prud'homme, Robert Hellwig, Bernhard Teupe
  • Patent number: 8945085
    Abstract: A method for calculating a bolus amount, wherein the bolus amount is calculated according to a basal rate, and a device for calculating a bolus amount according to the method, the device including an input unit used to input an amount of received carbohydrates, a computer coupled to the input unit and at least one interface used to transmit an actual blood glucose value and the value of the actual basal rate to the computer, wherein the at least one interface or another interface transmits a bolus amount calculated by the computer.
    Type: Grant
    Filed: September 7, 2006
    Date of Patent: February 3, 2015
    Assignee: Roche Diagnostics International AG
    Inventor: Robert Hellwig
  • Patent number: 8452953
    Abstract: Insulin pump programming software is disclosed that permits selectively modifying insulin pump configuration files. The software facilitates retrieving a source file consisting of a configuration file or portion thereof from a source location. The source file may include general configuration data and insulin delivery data. Once retrieved, the source file may be edited, then the entire source file or a portion thereof may be saved to a target configuration file at one or more target locations. Only the portion of the target configuration file corresponding to the saved source file or portion thereof is replaced by the source file.
    Type: Grant
    Filed: September 5, 2008
    Date of Patent: May 28, 2013
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Schuyler Buck, Jason Bush, Kristin Davenport, Alan Greenburg, Robert Hellwig, David Bradley Markisohn
  • Patent number: 8156070
    Abstract: Insulin pump programming software is disclosed that generates thumbnail images of basal rate profile data contained in source files and displays the images to permit an operator to select the desired profile data without opening the source files. The software also permits the operator to verify changes to pump profiles before programming the pump by displaying thumbnail images of the current pump profile and the new pump profile.
    Type: Grant
    Filed: September 5, 2008
    Date of Patent: April 10, 2012
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Schuyler Buck, Andreas Buhr, Jason Bush, Robert Hellwig, David Bradley Markisohn, Leon R. Organ, III
  • Patent number: 8149140
    Abstract: The present invention relates to a pressure-difference warning system comprising an acoustic signal device, comprising an energy supply device and comprising a pressure sensor. The pressure sensor is designed for measuring a pressure difference between an interior region and an exterior region. The energy supply device is designed for providing energy for operating the warning system. The acoustic signal device is designed for outputting an acoustic signal if the measured pressure difference exceeds a specifiable threshold value.
    Type: Grant
    Filed: January 19, 2006
    Date of Patent: April 3, 2012
    Assignee: Airbus Operations GmbH
    Inventor: Robert Hellwig
  • Patent number: 8118770
    Abstract: An electronic device may be configured to prompt a user via an on-board display to measure user glucose via an on-board glucose meter, to compute a first drug bolus value based on the measured user glucose, to display the first drug bolus value on the display and prompt the user via the display to enter carbohydrate information into the device, to compute a second drug bolus value based on the entered carbohydrate information, to display the second drug bolus value on the display and prompt the user via the display to enter user health information into the device, to compute a third drug bolus value based on the entered health information and a total drug bolus value as a sum of the first, second and third drug bolus values, and to display the third and total drug bolus values on the display.
    Type: Grant
    Filed: December 23, 2009
    Date of Patent: February 21, 2012
    Assignees: Roche Diagnostics Operations, Inc., Roche Diagnostics International Ltd.
    Inventors: Paul J. Galley, Maury Zivitz, Stefan Weinert, Robert Hellwig
  • Publication number: 20110238033
    Abstract: A diabetes therapy device is disclosed herein, which includes a profile memory storing a parameter profile and a dedicated reference time mark. The parameter profile defines at least one parameter that is associated with insulin administration as a function of time for a generally circadian chronobiological cycle. The reference time mark indicates the beginning of the circadian chronobiological cycle and initializes a running time. Insulin amounts to be administered are determined as a function of the running time in accordance with a current matching of the parameter profile. A modified matching based on the reference time mark and an upcoming trigger time is computed and is time-shifted from the current matching, wherein the modified matching is applied by making the modified matching the current matching, such that future insulin amounts to be administered are determined in accordance with the modified matching.
    Type: Application
    Filed: September 23, 2010
    Publication date: September 29, 2011
    Applicant: ROCHE DIAGNOSTICS INTERNATIONAL AG
    Inventors: Gilles Prod'hom, Thierry Prud'homme, Robert Hellwig, Bernhard Teupe
  • Patent number: 7869851
    Abstract: A method of computing an insulin bolus quantity when a measured glucose value in a current time interval exceeds a target glucose value for the current time interval and when a time duration of glucose lowering action of the bolus to be administered spans the current and a number of the next adjacent time intervals, may comprise determining a corresponding number of percentages of insulin action of the recommended bolus quantity that will each be used lowering the glucose level during a respective one of the number of time intervals, and computing the recommended bolus quantity as a function of the measured glucose value, the target blood glucose level for a last one of the number of next adjacent time intervals, the insulin sensitivities for the current and each of the number of next adjacent time intervals, and the corresponding number of percentages.
    Type: Grant
    Filed: December 23, 2004
    Date of Patent: January 11, 2011
    Assignees: Roche Diagnostics Operations, Inc., Roche Diagnostics International AG
    Inventors: Robert Hellwig, Stefan Weinert
  • Publication number: 20100168660
    Abstract: An electronic device may be configured to prompt a user via an on-board display to measure user glucose via an on-board glucose meter, to compute a first drug bolus value based on the measured user glucose, to display the first drug bolus value on the display and prompt the user via the display to enter carbohydrate information into the device, to compute a second drug bolus value based on the entered carbohydrate information, to display the second drug bolus value on the display and prompt the user via the display to enter user health information into the device, to compute a third drug bolus value based on the entered health information and a total drug bolus value as a sum of the first, second and third drug bolus values, and to display the third and total drug bolus values on the display.
    Type: Application
    Filed: December 23, 2009
    Publication date: July 1, 2010
    Inventors: Paul J. Galley, Maury Zivitz, Stefan Weinert, Robert Hellwig
  • Publication number: 20100077198
    Abstract: Insulin pump programming software is disclosed that permits selectively modifying insulin pump configuration files. The software facilitates retrieving a source file consisting of a configuration file or portion thereof from a source location. The source file may include general configuration data and insulin delivery data. Once retrieved, the source file may be edited, then the entire source file or a portion thereof may be saved to a target configuration file at one or more target locations. Only the portion of the target configuration file corresponding to the saved source file or portion thereof is replaced by the source file.
    Type: Application
    Filed: September 5, 2008
    Publication date: March 25, 2010
    Inventors: Schuyler Buck, Jason Bush, Kristin Davenport, Alan Greenburg, Robert Hellwig, David Bradley Markisohn
  • Publication number: 20100064236
    Abstract: Insulin pump programming software is disclosed that generates thumbnail images of basal rate profile data contained in source files and displays the images to permit an operator to select the desired profile data without opening the source files. The software also permits the operator to verify changes to pump profiles before programming the pump by displaying thumbnail images of the current pump profile and the new pump profile.
    Type: Application
    Filed: September 5, 2008
    Publication date: March 11, 2010
    Inventors: Schuyler Buck, Andreas Buhr, Jason Bush, Robert Hellwig, David Bradley Markisohn, Leon R. Organ, III
  • Publication number: 20090222247
    Abstract: A system and method are provided for generating a plurality of basal rate models that together model delivery of a corresponding plurality of basal rates of a diabetes treatment drug to a patient over a period of time. Information may be collected from a plurality of patients that have a diabetic condition and to which the diabetes treatment drug has been delivered. The collected information may include a glycemic control indicator for each of the plurality of patients that is indicative of an efficacy of the diabetes treatment drug in treating the patient's diabetic condition. The collected information may be filtered based on the glycemic control indicators to produce a subset of information that includes information only for patients that exhibit acceptable glycemic control. The plurality of basal rate models may be generated based on the subset of the collected information, and may be stored in a memory unit.
    Type: Application
    Filed: February 28, 2008
    Publication date: September 3, 2009
    Inventors: Robert Hellwig, Wim Van der Helm, Stefan Weinert
  • Patent number: 7553281
    Abstract: A system for recommending insulin bolus quantities to an insulin user includes a display unit and memory unit coupled to a control circuit with a user blood glucose target stored in the memory unit. The control circuit is programmed to receive the user's current blood glucose value, to determine and display via the display unit a recommended correction insulin bolus quantity if the current blood glucose value exceeds the blood glucose target, to compute a difference value as the current blood glucose value less the blood glucose target, and to produce a modified blood glucose target as a sum of the blood glucose target and the difference value for a lock-out time period if the difference value is positive. Additional correction insulin bolus quantities may be recommended during the lock-out time period if the user's current blood glucose value exceeds the modified blood glucose target.
    Type: Grant
    Filed: October 5, 2007
    Date of Patent: June 30, 2009
    Assignees: Roche Diagnostices Operations, Inc., Disetronic Licensing AG
    Inventors: Robert Hellwig, Stefan Weinert
  • Publication number: 20080088483
    Abstract: The present invention relates to a pressure-difference warning system comprising an acoustic signal device, comprising an energy supply device and comprising a pressure sensor. The pressure sensor is designed for measuring a pressure difference between an interior region and an exterior region. The energy supply device is designed for providing energy for operating the warning system. The acoustic signal device is designed for outputting an acoustic signal if the measured pressure difference exceeds a specifiable threshold value.
    Type: Application
    Filed: January 19, 2006
    Publication date: April 17, 2008
    Applicant: AIRBUS DEUTSCHLAND GMBH
    Inventor: Robert Hellwig
  • Publication number: 20080058628
    Abstract: A system for recommending insulin bolus quantities to an insulin user includes a display unit and memory unit coupled to a control circuit with a user blood glucose target stored in the memory unit. The control circuit is programmed to receive the user's current blood glucose value, to determine and display via the display unit a recommended correction insulin bolus quantity if the current blood glucose value exceeds the blood glucose target, to compute a difference value as the current blood glucose value less the blood glucose target, and to produce a modified blood glucose target as a sum of the blood glucose target and the difference value for a lock-out time period if the difference value is positive. Additional correction insulin bolus quantities may be recommended during the lock-out time period if the user's current blood glucose value exceeds the modified blood glucose target.
    Type: Application
    Filed: October 5, 2007
    Publication date: March 6, 2008
    Inventors: Robert Hellwig, Stefan Weinert
  • Publication number: 20070282299
    Abstract: A method for calculating a bolus amount, wherein the bolus amount is calculated according to a basal rate, and a device for calculating a bolus amount according to the method, the device including an input unit used to input an amount of received carbohydrates, a computer coupled to the input unit and at least one interface used to transmit an actual blood glucose value and the value of the actual basal rate to the computer, wherein the at least one interface or another interface transmits a bolus amount calculated by the computer.
    Type: Application
    Filed: September 7, 2006
    Publication date: December 6, 2007
    Inventor: Robert Hellwig
  • Patent number: 7291107
    Abstract: A system for recommending insulin bolus quantities to an insulin user includes a display unit and memory unit coupled to a control circuit with a user blood glucose target stored in the memory unit. The control circuit is programmed to receive the user's current blood glucose value, to determine and display via the display unit a recommended correction insulin bolus quantity if the current blood glucose value exceeds the blood glucose target, to compute a difference value as the current blood glucose value less the blood glucose target, and to produce a modified blood glucose target as a sum of the blood glucose target and the difference value for a lock-out time period if the difference value is positive. Additional correction insulin bolus quantities may be recommended during the lock-out time period if the user's current blood glucose value exceeds the modified blood glucose target.
    Type: Grant
    Filed: August 26, 2004
    Date of Patent: November 6, 2007
    Assignees: Roche Diagnostics Operations, Inc., Disetronic Licensing AG
    Inventors: Robert Hellwig, Stefan Weinert
  • Publication number: 20060137695
    Abstract: A method of computing an insulin bolus quantity when a measured glucose value in a current time interval exceeds a target glucose value for the current time interval and when a time duration of glucose lowering action of the bolus to be administered spans the current and a number of the next adjacent time intervals, may comprise determining a corresponding number of percentages of insulin action of the recommended bolus quantity that will each be used lowering the glucose level during a respective one of the number of time intervals, and computing the recommended bolus quantity as a function of the measured glucose value, the target blood glucose level for a last one of the number of next adjacent time intervals, the insulin sensitivities for the current and each of the number of next adjacent time intervals, and the corresponding number of percentages.
    Type: Application
    Filed: December 23, 2004
    Publication date: June 29, 2006
    Inventors: Robert Hellwig, Stefan Weinert
  • Publication number: 20060047192
    Abstract: A system for recommending insulin bolus quantities to an insulin user includes a display unit and memory unit coupled to a control circuit with a user blood glucose target stored in the memory unit. The control circuit is programmed to receive the user's current blood glucose value, to determine and display via the display unit a recommended correction insulin bolus quantity if the current blood glucose value exceeds the blood glucose target, to compute a difference value as the current blood glucose value less the blood glucose target, and to produce a modified blood glucose target as a sum of the blood glucose target and the difference value for a lock-out time period if the difference value is positive. Additional correction insulin bolus quantities may be recommended during the lock-out time period if the user's current blood glucose value exceeds the modified blood glucose target.
    Type: Application
    Filed: August 26, 2004
    Publication date: March 2, 2006
    Inventors: Robert Hellwig, Stefan Weinert